Merck KGaA: Top-line results of peg IFN beta-1a from Biogen show competitive profile in the IFN world

NEUTRAL, Fair Value EUR100 (-2%)

News published on January Friday 25, 2013
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Recent Transactions Highlights
From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities